BNP Paribas Downgrades Fresenius Medical Care to Underperform, Lifts PT

MT Newswires · 2d ago
08:34 AM EDT, 07/28/2026 (MT Newswires) -- BNP Paribas on Tuesday downgraded healthcare company Fresenius Medical Care (FME.F) to underperform from neutral while raising its price target to 35 euros from 34.50 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)